ICIG purchases Clariant AG unit focused on detergent and other intermediate chemicals. The plan of Clariant CEO Hariolf Kottmann of focusing the Swiss company to high yield markets would be one step closer to realization.
Investors
Twitter chooses NYSE
In its amended IPO filing, Twitter would be listed with the NYSE and also reported increased revenues and user base despite mounting losses.
Chalco to divest shares in Guinea venture with Rio Tinto
The Aluminum Corporation of China Ltd or Chalco had announced the sale of its shareholdings in the Guinea venture with Rio Tinto.
Cerberus contemplating bid for beleaguered BlackBerry
Known institutional investor Cerberus Capital Management is studying its options to determine if it would make a bid for BlackBerry.
Homebuilder KB Home offers bonds to retire debt
KB Home set to offer bonds as well as notes issued to assist its plan to retire soon to be maturing debt.
Latest News
The plan is to raise funds from a share sale of Huaneng Renewables Corp. Wind farm operator from China, Huaneng Renewables Corp, is planning to raise HKD1.
A number of top notch companies have sent their bids to build Mongolia's Tavan Tolgoi Power Plant.
SundaySky, a smart video ad company, raised USD20 million in its Series C financing round led by Comcast Ventures.
Japanese firms Softbank Corp and games developer GungHo OnLine Entertainment had purchased a controlling stake in Supercell for USD1.53 billion.
IVC with KPMG worked to draft a report on the progress of venture capital investments in Israel. In a report from Reuters, Israeli technology firms have raised USD660 million in venture in the third quarter.
Albion Ventures, the largest venture capitalist in the UK completed the investment in Cisiv Ltd. Albion Ventures recently completed the acquisition of Cisiv Ltd.
Investment firm Triton had stepped in as the possible buyer of Siemens AG's postal automation and baggage-handling division unit after Sun Capital dropped out of the bidding round.
Siemens AG's talks with equity group AEA Investors were at the advance stage regarding the German company's sale of its water technologies business.
immatics raises EUR34 million in its latest Series D round financing. Clinical stage biopharmaceutical firm immatics biotechnologies GmbH had developed advanced a multi-peptide vaccine program providing active medication against cancer.
